Skip to main content
. 2019 Nov 19;18(3):393–411. doi: 10.1007/s40258-019-00536-w

Table 2.

Cumulative costs in different arms of cost-effectiveness model for India

Type of cost Costs (in millions) Incremental costs (in millions)
INR USD INT. $ LL (INR) UL (INR) INR USD INT. $ LL (INR) UL (INR)
Disposable (counterfactual)
Syringesa 70,270 1081 3253 40,682 190,029
Biowaste Management 84 1.30 3.90
Treatmentb 98,527 1516 4561 30,694 176,989
Total
 Undiscounted 168,882 2598 7817 91,264 317,531
 Discounted 111,271 1712 5150 56,837 214,763
RUP
Syringes 286,538 4408 13,263 193,703 349,155 216,268 3327 10,011 91,691 265,104
Training 2 0.03 0.09
Information Education and Communication (IEC) 6 0.09 0.26
Biowaste Management 205 3.15 9.48 120 2 6
Treatment 4325 66.53 200.17 1491 9190 − 94,203 − 1449 − 4360 − 29,426 − 169,914
Total
 Undiscounted 291,075 4478 13,473 199,170 354,067 122,193 1880 5656 − 32,988 201,564
 Discounted 219,276 3373 10,150 138,256 271,205 108,005 1662 4999 − 2568 153,493
SIP
Syringes 750,457 11,545 34,737 460,290 1146,126 680,187 10,464 31,484 371,549 1,032,550
Training 2 0.03 0.09
Information Education and Communication (IEC) 6 0.09 0.26
Biowaste Management 93 1.43 4.29 8 0 0
Treatment 92,804 1428 4296 39,026 231,525 − 5723 − 88 − 265 − 1993 − 17,123
Total
 Undiscounted 843,362 12,975 39,037 552,192 1,278,420 674,480 10,377 31,220 362,871 1,024,639
 Discounted 622,080 9570 28,795 374,133 930,330 510,810 7859 23,644 263,392 754,558
RUP + SIP
Syringes 750,457 11,545 34,737 349,454 1,211,036 680,187 10,464 31,484 258,418 1,093,217
Training 2 0.03 0.09
Information Education and Communication (IEC) 6 0.09 0.26
Biowaste Management 93 1.43 4.29 8 0 0
Treatment 519 7.99 24.03 174 1236 − 98,008 − 1508 − 4108 − 28,192 − 178,208
Total
 Undiscounted 751,076 11,555 34,766 349,892 1,211,948 582,194 8957 26,948 153,643 1,001,002
 Discounted 567,777 8735 26,281 244,102 903,246 456,506 7023 21,131 127,635 745,537

INR Indian National Rupee, USD United States dollar, INT. $ International Dollar, LL lower limit, UL upper limit

aSyringe cost shows cost of disposable/SES syringes for the period from 2017–2036

bTreatment cost shows lifetime cost of treating individuals infected with hepatitis B, hepatitis C and HIV as a result of unsafe injection practices